2026-03-06 Lucid News

Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation

Research

While psychedelics have a history of sparking creativity, the first modern study to investigate the potential of psilocybin to enhance the brain’s ability to unlock creativity and problem solving is underway at the University of Texas, Austin and groups like Center for MINDS is exploring this connection. The post Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation first appeared on Lucid News. The post Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation appeared first on Lucid News.

External link. We are not responsible for the content.

Read more ↗

More From Lucid News

2026-04-17 Lucid News

Evaluating the Pros and Cons of State Psychedelic Task Forces

While state legislatures across the U.S. are creating task forces to evaluate proposed legislation to regulate psych...

2026-04-13 Lucid News

New Orleans Hosts Psychedelic Research Conference Double-Header

Over the last week in February, more than 200 people from psychedelic drug development companies, clinical researcher...

Research Policy
2026-04-11 Lucid News

Turning On The Culture

Author and therapist Charles Wininger asks what would happen if millions of people across the political spectrum aros...

Policy

Latest News

2026-04-19 The Psychedelic Blog (Substack)

Global Altered States: The Storefront Psychedelic

This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.

2026-04-19 Chemical Collective

Psychonautisme, Herbes et Suppléments

De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la n...

2026-04-18 MAPS

MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy

April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements fro...

2026-04-17 Psychedelics Today

Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols

What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West ...

2026-04-17 The Microdose (Berkeley)

Scientists test if ketamine has antidepressant effects under anesthesia; France is the first to approve IV ketamine for severe suicidal crisis

Plus: New research on the role of trip sitters; Various state bills move to expand psychedelics research and access

2026-04-17 The Psychedelic Blog (Substack)

The Life You Call “Normal” Was Designed

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.